Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy. Issue 2 (9th January 2009) - Liu, C-H; Liang, C-C; Liu, C-J; Tsai, H-B; Hung, P-H; Hsu, S-J; Chen, S-I; Lin, J-W; Lai, M-Y; Chen, J-H; Chen, P-J; Chen, D-S; et al.